|
RAD51C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.241500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.041200E-03 |
| Normal-vs-Stage2 |
1.508340E-02 |
| Normal-vs-Stage3 |
2.693200E-01 |
| Normal-vs-Stage4 |
2.272800E-01 |
| Stage1-vs-Stage2 |
9.643600E-01 |
| Stage1-vs-Stage3 |
1.279360E-01 |
| Stage1-vs-Stage4 |
9.116400E-01 |
| Stage2-vs-Stage3 |
1.891210E-01 |
| Stage2-vs-Stage4 |
9.319800E-01 |
| Stage3-vs-Stage4 |
4.663800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.399000E-04 |
| Normal-vs-AfricanAmerican |
4.100000E-02 |
| Normal-vs-Asian |
6.914200E-02 |
| Caucasian-vs-AfricanAmerican |
1.170960E-01 |
| Caucasian-vs-Asian |
9.141400E-01 |
| AfricanAmerican-vs-Asian |
4.577000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.382300E-03 |
| Normal-vs-Female |
1.370930E-04 |
| Male-vs-Female |
5.784400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.367800E-02 |
| Normal-vs-Extreme_Weight |
5.256800E-03 |
| Normal-vs-Obese |
1.018470E-02 |
| Normal-vs-Extreme_Obese |
1.207370E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.290600E-01 |
| Normal_Weight-vs-Obese |
6.738400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.523000E-01 |
| Extreme_Weight-vs-Obese |
8.226200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.486200E-01 |
| Obese-vs-Extreme_Obese |
8.369600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.297740E-03 |
| Normal-vs-Age(41-60Yrs) |
1.056120E-03 |
| Normal-vs-Age(61-80Yrs) |
9.736700E-03 |
| Normal-vs-Age(81-100Yrs) |
8.563800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.966210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.190640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.149600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.294800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.383600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.218420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.54699999999864E-05 |
| Normal-VS-Type2 PRCC |
6.507800E-01 |
| Normal-VS-KIRP CIMP |
5.754400E-02 |
| Normal-VS-Unclassified PRCC |
6.970500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.27330000005066E-06 |
| Type1 PRCC-VS-KIRP CIMP |
5.688000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.028600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.574360E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.078140E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.162000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.547600E-02 |
| Normal-vs-N1 |
3.834100E-02 |
| Normal-vs-N2 |
6.882600E-01 |
| N0-vs-N1 |
2.966000E-01 |
| N0-vs-N2 |
6.499000E-01 |
| N1-vs-N2 |
4.889200E-01 |
|
|
